Shuli Zhao

2.9k total citations
78 papers, 2.1k citations indexed

About

Shuli Zhao is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Shuli Zhao has authored 78 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 33 papers in Immunology and 18 papers in Oncology. Recurrent topics in Shuli Zhao's work include Immune Cell Function and Interaction (13 papers), Immune cells in cancer (12 papers) and MicroRNA in disease regulation (9 papers). Shuli Zhao is often cited by papers focused on Immune Cell Function and Interaction (13 papers), Immune cells in cancer (12 papers) and MicroRNA in disease regulation (9 papers). Shuli Zhao collaborates with scholars based in China, United States and Netherlands. Shuli Zhao's co-authors include Yayi Hou, Qiong‐Yu Mi, Jingyan Xie, Yunzhong Nie, Qianming Du, Xiuting Liu, Jianjun Zou, Yubing Zhu, Zhigang Cao and Tingting Wang and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Shuli Zhao

72 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuli Zhao China 27 1.1k 723 489 484 182 78 2.1k
Xingbin Hu China 20 1.2k 1.1× 607 0.8× 393 0.8× 523 1.1× 267 1.5× 65 2.4k
Kazimierz Węglarczyk Poland 21 1.4k 1.2× 517 0.7× 385 0.8× 684 1.4× 113 0.6× 62 2.1k
Haiyoung Jung South Korea 33 1.4k 1.3× 936 1.3× 534 1.1× 329 0.7× 164 0.9× 87 2.8k
Xuesong Wu China 29 912 0.8× 787 1.1× 554 1.1× 328 0.7× 225 1.2× 90 2.2k
Xiuting Liu China 22 1.0k 0.9× 663 0.9× 488 1.0× 282 0.6× 158 0.9× 46 1.9k
Shaohui Cai China 26 1.3k 1.2× 688 1.0× 969 2.0× 472 1.0× 174 1.0× 65 2.5k
Luis Gil‐de‐Gómez Spain 14 851 0.8× 719 1.0× 399 0.8× 396 0.8× 139 0.8× 19 1.7k
Serafim Kiriakidis United Kingdom 26 965 0.9× 739 1.0× 416 0.9× 674 1.4× 216 1.2× 42 2.6k
Stavroula Baritaki Greece 31 1.5k 1.4× 492 0.7× 715 1.5× 571 1.2× 232 1.3× 96 2.6k

Countries citing papers authored by Shuli Zhao

Since Specialization
Citations

This map shows the geographic impact of Shuli Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuli Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuli Zhao more than expected).

Fields of papers citing papers by Shuli Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuli Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuli Zhao. The network helps show where Shuli Zhao may publish in the future.

Co-authorship network of co-authors of Shuli Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Shuli Zhao. A scholar is included among the top collaborators of Shuli Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuli Zhao. Shuli Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yue, Xinxin Zhang, Lu Wang, et al.. (2025). CD81 Aggravates Ovarian Cancer Progression via p‐Cresyl Sulfate‐Mediated Mitophagy in Tim4+ Tumour‐Associated Macrophages. Journal of Cellular and Molecular Medicine. 29(13). e70701–e70701. 1 indexed citations
2.
Zhang, Mengjie, Yi‐Rong Chen, Caixia Zhang, et al.. (2025). Development of a 177Lu-labeled EphA2-targeting cyclic peptide combined with an HPK1 inhibitor for synergistic anti-tumor effects. Cellular Oncology. 48(6). 1757–1774.
3.
Zhao, Shuli, et al.. (2024). Human β-defensins: The multi-functional natural peptide. Biochemical Pharmacology. 227. 116451–116451. 2 indexed citations
4.
Cao, Yuanyuan, Xiaofeng Bian, Yi‐Rong Chen, et al.. (2024). ETS1 deficiency in macrophages suppresses colorectal cancer progression by reducing the F4/80+TIM4+ macrophage population. Carcinogenesis. 45(10). 745–758. 2 indexed citations
5.
Tan, Liping, Na Sai, Y Mao, et al.. (2024). FoxO1 promotes ovarian cancer by increasing transcription and METTL14‐mediated m6A modification of SMC4. Cancer Science. 115(4). 1224–1240. 8 indexed citations
6.
Li, Haiyang, Na Zheng, Weiwei Tang, et al.. (2024). FSTL3 promotes tumor immune evasion and attenuates response to anti-PD1 therapy by stabilizing c-Myc in colorectal cancer. Cell Death and Disease. 15(2). 107–107. 9 indexed citations
7.
Wang, Xiaogang, Xiang Chen, Peng Chen, et al.. (2023). 2bRAD-M reveals the difference in microbial distribution between cancerous and benign ovarian tissues. Frontiers in Microbiology. 14. 1231354–1231354. 5 indexed citations
8.
Li, Yanchuan, Lele Zhu, Chun‐Jung Ko, et al.. (2023). TRAF3–EWSR1 signaling axis acts as a checkpoint on germinal center responses. The Journal of Experimental Medicine. 220(8). 1 indexed citations
9.
Wang, Xiaogang, Qianyu Chen, Zhen Xu, et al.. (2023). Low expression of m6A reader YTHDC1 promotes progression of ovarian cancer via PIK3R1/STAT3/GANAB axis. International Journal of Biological Sciences. 19(14). 4672–4688. 10 indexed citations
10.
11.
Li, Haiyang, Cheng Zeng, Chang Shu, et al.. (2022). Laminins in tumor-derived exosomes upregulated by ETS1 reprogram omental macrophages to promote omental metastasis of ovarian cancer. Cell Death and Disease. 13(12). 1028–1028. 30 indexed citations
12.
Peng, Jianqing, Qin Wang, Jia Zhou, et al.. (2021). Targeted Lipid Nanoparticles Encapsulating Dihydroartemisinin and Chloroquine Phosphate for Suppressing the Proliferation and Liver Metastasis of Colorectal Cancer. Frontiers in Pharmacology. 12. 720777–720777. 18 indexed citations
13.
Liu, Xinghan, Yujun Xu, Lijie Yin, Yayi Hou, & Shuli Zhao. (2021). Chitosan-Poly(Acrylic Acid) Nanoparticles Loaded with R848 and MnCl2 Inhibit Melanoma via Regulating Macrophage Polarization and Dendritic Cell Maturation. International Journal of Nanomedicine. Volume 16. 5675–5692. 23 indexed citations
14.
Cao, Zhigang, Li Xu, & Shuli Zhao. (2019). Exosome-derived miR-27a produced by PSC-27 cells contributes to prostate cancer chemoresistance through p53. Biochemical and Biophysical Research Communications. 515(2). 345–351. 46 indexed citations
15.
Xu, Zhuo, Jinping Bai, Shuli Zhao, et al.. (2016). Umbilical Cord Tissue‐Derived Mesenchymal Stem Cells Induce T Lymphocyte Apoptosis and Cell Cycle Arrest by Expression of Indoleamine 2, 3‐Dioxygenase. Stem Cells International. 2016(1). 7495135–7495135. 46 indexed citations
16.
Zhang, Xiuqun, Long Wang, Shuli Zhao, & Wei Xu. (2014). In vitro cultivation of rat bone marrow mesenchymal stem cells and establishment of pEGFP/Ang-1 transfection method. Asian Pacific Journal of Tropical Biomedicine. 4(9). 701–706.
17.
Song, Yuxian, Huan Dou, Ping Wang, et al.. (2014). A novel small-molecule compound diaporine A inhibits non-small cell lung cancer growth by regulating miR-99a/mTOR signaling. Cancer Biology & Therapy. 15(10). 1423–1430. 22 indexed citations
18.
Ren, Jing, Yunzhong Nie, Mingming Lv, et al.. (2014). Estrogen upregulates MICA/B expression in human non-small cell lung cancer through the regulation of ADAM17. Cellular and Molecular Immunology. 12(6). 768–776. 46 indexed citations
19.
Zhao, Shuli, Yunzhong Nie, Lulu Chen, & Yayi Hou. (2012). Ganoderma lucidum polysaccharides combined with low-dose cisplatin inhibits tumor growth and enhances the immune function of tumor-bearing mice. Traditional Chinese Medicine. 34(12). 1084–1087. 1 indexed citations
20.
Zhao, Shuli, Huijuan Wang, Yunzhong Nie, et al.. (2012). Midkine upregulates MICA/B expression in human gastric cancer cells and decreases natural killer cell cytotoxicity. Cancer Immunology Immunotherapy. 61(10). 1745–1753. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xingbin Hu Breakdown of academic impact, for papers by Kazimierz Węglarczyk Breakdown of academic impact, for papers by Haiyoung Jung Breakdown of academic impact, for papers by Xuesong Wu Breakdown of academic impact, for papers by Xiuting Liu Breakdown of academic impact, for papers by Shaohui Cai Breakdown of academic impact, for papers by Luis Gil‐de‐Gómez Breakdown of academic impact, for papers by Serafim Kiriakidis Breakdown of academic impact, for papers by Stavroula Baritaki
Rankless by CCL
2026